REGγ controls Th17 cell differentiation and autoimmune inflammation by regulating dendritic cells
Lei Zhou,Liangfang Yao,Qing Zhang,Wei Xie,Xiaoshuang Wang,Huihui Zhang,Jinjin Xu,Qingxia Lin,Qing Li,Yang Xuan,Lei Ji,Lu Wang,Weicang Wang,Weichao Wang,Tingting Shi,Lei Fang,Biao Zheng,Lei Li,Shuang Liu,Bianhong Zhang,Xiaotao Li
DOI: https://doi.org/10.1038/s41423-019-0287-0
2019-09-11
Cellular and Molecular Immunology
Abstract:Interleukin-17A (IL-17A)-producing helper T (Th17) cells are a subset of CD4<sup>+</sup> T cells that play important pathological roles in autoimmune diseases. Although the intrinsic pathways of Th17 cell differentiation have been well described, how instructive signals derived from the innate immune system trigger the Th17 response and inflammation remains poorly understood. Here, we report that mice deficient in REGγ, a proteasome activator belonging to the 11S family, exhibit significantly deteriorated autoimmune neuroinflammation in an experimental autoimmune encephalomyelitis (EAE) model with augmented Th17 cell polarization in vivo. The results of the adoptive transfer of CD4<sup>+</sup> T cells or dendritic cells (DCs) suggest that this phenotype is driven by DCs rather than T cells. Furthermore, REGγ deficiency promotes the expression of integrin αvβ8 on DCs, which activates the maturation of TGF-β1 to enhance Th17 cell development. Mechanistically, this process is mediated by the REGγ-proteasome-dependent degradation of IRF8, a transcription factor for αvβ8. Collectively, our findings delineate a previously unknown mechanism by which REGγ-mediated protein degradation in DCs controls the differentiation of Th17 cells and the onset of an experimental autoimmune disease.
immunology